Background:
Phosphatase and tensin homolog, widely known as PTEN, is a major negative regulator of the PI3K/AKT/mTOR signaling pathway, involved in the regulation of a variety of
important cellular processes, including cell proliferation, growth, survival, and metabolism. Since
most of the molecules involved in this biological pathway have been described as key regulators in
cancer, the study of the corresponding genes at several levels is crucial.
Objective:
Although previous studies have elucidated the physiological role of PTEN under normal
conditions and its involvement in carcinogenesis and cancer progression, the transcriptional profile
of PTEN has been poorly investigated.
Methods:
In this study, instead of conducting the “gold-standard” direct RNA sequencing that fails
to detect less abundant novel mRNAs due to the decreased sequencing depth, we designed and implemented a multiplexed PTEN-targeted sequencing approach that combined both short- and longread sequencing.
Results:
Our study has highlighted a broad spectrum of previously unknown PTEN mRNA transcripts and assessed their expression patterns in a wide range of human cancer and non-cancer cell
lines, shedding light on the involvement of PTEN in cell cycle dysregulation and thus tumor development.
Conclusion:
The identification of the described novel PTEN splice variants could have significant
implications for understanding PTEN regulation and function, and provide new insights into PTEN
biology, opening new avenues for monitoring PTEN-related diseases, including cancer.